| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Morphic Holding, Inc. | CMO | Restricted Stock Unit | 7K | $192K | $27.49 | Mar 18, 2024 | Direct |
| Morphic Holding, Inc. | CMO | Restricted Stock Unit | 0 | $0 | $55.79 | Aug 16, 2024 | Direct |
| Morphic Holding, Inc. | CMO | Employee Stock Options (right to buy) | 170K | Mar 18, 2024 | Direct | ||
| Keros Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Employee Stock Option (right to buy) | 40K | Feb 13, 2024 | Direct | ||
| Morphic Holding, Inc. | CMO | Stock Option (Right to Buy) | 0 | Aug 16, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MORF | Morphic Holding, Inc. | Aug 16, 2024 | 3 | $0 | 4 | Aug 20, 2024 | CMO |
| MORF | Morphic Holding, Inc. | Mar 18, 2024 | 3 | $0 | 4 | Mar 19, 2024 | CMO |
| MORF | Morphic Holding, Inc. | Mar 18, 2024 | 0 | $0 | 3 | Mar 19, 2024 | CMO |
| KROS | Keros Therapeutics, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | CHIEF MEDICAL OFFICER |
| KROS | Keros Therapeutics, Inc. | Feb 16, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Chief Medical Officer |
| KROS | Keros Therapeutics, Inc. | Jan 21, 2022 | 1 | $0 | 4 | Jan 25, 2022 | Chief Medical Officer |
| KROS | Keros Therapeutics, Inc. | Aug 10, 2021 | 1 | $0 | 4 | Aug 11, 2021 | Chief Medical Officer |
| KROS | Keros Therapeutics, Inc. | Aug 2, 2021 | 0 | $0 | 3 | Aug 11, 2021 | Chief Medical Officer |